Exane BNP Paribas analyst Rob Jones upgraded Gecina to Outperform from Neutral with a EUR 120 price target. The analyst sees the stock as undervalued following the recent underperformance.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GECFF: